“Paul Pelosi bought 25 call options costing between $500,000 and $1 million, according to a financial disclosure dated Jan. 21 reviewed by FOX Business…
GOP Rep. Chris Collins Resigns Amid Insider Trading Scandal…
Four-term Republican Rep. Chris Collins of New York submitted his resignation from Congress Monday, one day before he’s expected to plead guilty to charges of insider trading. House Speaker Nancy Pelosi “is in receipt of a letter of resignation” from Collins, which will be made effective Tuesday morning when it’s brought to the floor of […]
Sen. Jeff Merkley Wants to Stop Congress Members from Insider Trading by Banning Them from Owning Stocks…
Sen. James Inhofe, an Oklahoma Republican recently elevated to chair the Senate Armed Services Committee after the death of John McCain, was implicated recently in what looked to be an insider trading scandal. A few days after meeting with President Donald Trump and Secretary of Defense Jim Mattis to successfully advocate for a military budget […]
U.S. Senator on Equifax Hack: ‘Somebody Needs to Go to Jail’…
Thirty-six U.S. senators on Tuesday called on federal authorities to investigate the sale of nearly $2 million in shares of credit bureau Equifax Inc (EFX.N) by company executives after a massive data breach, and one compared their actions to insider trading. The lawmakers signed a letter asking the U.S. Department of Justice…
Hedge Funds Are the Robber Barons of Our Time (Podcast)…
The hedge fund industry grew up quietly out of almost nothing into this enormous force on Wall Street. There’s almost $3 trillion estimated to be under management at hedge funds around the world — but hedge funds are lightly regulated, so we don’t always know what’s going on in that sector. The people who have […]
SCOTUS Rulings: Court Upholds ‘Friends and Family’ Insider-Trading Conviction…
Hedge Fund Manager Charged In Insider Trading Case Commits Suicide…
U.S. Attorney Preet Bharara in Manhattan charged Sanjay Valvani of fraudulently making $25 million by gaining advance word about FDA approvals of generic drug applications…